Intercellular: Local and systemic actions of skeletal muscle PGC-1s

Trends in Endocrinology and Metabolism

Volumn 26, Issue 6, 2015, Pages 305-314

  Correia, Jorge C ^a   Ferreira, Duarte M S ^a   Ruas, Jorge L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atrophy; Coactivators; Hypertrophy; Metabolism; PGC 1; Skeletal muscle

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; UNCLASSIFIED DRUG; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; TRANSCRIPTION FACTOR;

ANGIOGENESIS; CELL COMMUNICATION; CELL ENERGY; CENTRAL NERVOUS SYSTEM; HUMAN; INFLAMMATION; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; ANIMAL; ENERGY METABOLISM; EXERCISE; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ENERGY METABOLISM; EXERCISE; HUMANS; MUSCLE, SKELETAL; TRANSCRIPTION FACTORS;

EID: 84930040970     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.03.010     Document Type: Review

References (103)

1. Puigserver P., et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
2. Lin J., et al. Peroxisome proliferator-activated receptor gamma coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 2002, 277:1645-1648.
3. Andersson U., Scarpulla R.C. Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol. Cell. Biol. 2001, 21:3738-3749.
4. 2-adrenergic receptor activation and exercise. Endocrinology 2008, 149:4527-4533.
5. Chinsomboon J., et al. The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21401-21406.
6. Zhang Y., et al. Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1α. J. Biol. Chem. 2009, 284:32813-32826.
7. Ruas J.L., et al. A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 2012, 151:1319-1331.
8. Lin J., et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801.
9. Yoon J.C., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
10. Lin J., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell 2004, 119:121-135.
11. Lehman J.J., et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 2000, 106:847-856.
12. Sandri M., et al. PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16260-16265.
13. Wenz T., et al. Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20405-20410.
14. Brault J.J., et al. Peroxisome proliferator-activated receptor gamma coactivator 1α or 1β overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy. J. Biol. Chem. 2010, 285:19460-19471.
15. Hindi S.M., et al. Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program. FASEB J. 2014, 28:1398-1411.
16. Cannavino J., et al. The role of alterations in mitochondrial dynamics and PGC-1α over-expression in fast muscle atrophy following hindlimb unloading. J. Physiol. 2015, 593:1981-1995.
17. Suetta C., et al. Aging affects the transcriptional regulation of human skeletal muscle disuse atrophy. PLoS ONE 2012, 7:e51238.
18. Wall B.T., et al. Short-term muscle disuse atrophy is not associated with increased intramuscular lipid deposition or a decline in the maximal activity of key mitochondrial enzymes in young and older males. Exp. Gerontol. 2015, 61:76-83.
19. Sczelecki S., et al. Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation. Am. J. Physiol. Endocrinol. Metab. 2014, 306:E157-E167.
20. Safdar A., et al. Aberrant mitochondrial homeostasis in the skeletal muscle of sedentary older adults. PLoS ONE 2010, 5:e10778.
21. Dogra C., et al. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J. 2007, 21:1857-1869.
22. Handschin C., et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J. Biol. Chem. 2007, 282:30014-30021.
23. Menconi M.J., et al. Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1β in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E533-E543.
24. Philp A., et al. The PGC-1α-related coactivator promotes mitochondrial and myogenic adaptations in C2C12 myotubes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R864-R872.
25. Egan B., et al. Time course analysis reveals gene-specific transcript and protein kinetics of adaptation to short-term aerobic exercise training in human skeletal muscle. PLoS ONE 2013, 8:e74098.
26. Wagatsuma A., et al. Mitochondrial adaptations in skeletal muscle to hindlimb unloading. Mol. Cell. Biochem. 2011, 350:1-11.
27. Summermatter S., et al. Remodeling of calcium handling in skeletal muscle through PGC-1α: impact on force, fatigability, and fiber type. Am. J. Physiol. Cell Physiol. 2012, 302:C88-C99.
28. White J.P., et al. G protein-coupled receptor 56 regulates mechanical overload-induced muscle hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:15756-15761.
29. Perez-Schindler J., et al. The transcriptional coactivator PGC-1α is dispensable for chronic overload-induced skeletal muscle hypertrophy and metabolic remodeling. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:20314-20319.
30. Spangenburg E.E., et al. A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J. Physiol. 2008, 586:283-291.
31. Arany Z., et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1 alpha. Nature 2008, 451:1008-1012.
32. Rowe G.C., et al. PGC-1β regulates angiogenesis in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E155-E163.
33. Rowe G.C., et al. PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circ. Res. 2014, 115:504-517.
34. Henry T.D., et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 2003, 107:1359-1365.
35. Leick L., et al. PGC-1α mediates exercise-induced skeletal muscle VEGF expression in mice. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E92-E103.
36. Thom R., et al. Hypoxic induction of vascular endothelial growth factor (VEGF) and angiogenesis in muscle by truncated peroxisome proliferator-activated receptor gamma coactivator (PGC)-1α. J. Biol. Chem. 2014, 289:8810-8817.
37. Tadaishi M., et al. Skeletal muscle-specific expression of PGC-1α-b, an exercise-responsive isoform, increases exercise capacity and peak oxygen uptake. PLoS ONE 2011, 6:e28290.
38. Handschin C., et al. PGC-1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. 2007, 21:770-783.
39. Arnold A.S., et al. Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-1α. Nat. Commun. 2014, 5:3569.
40. Chan M.C., et al. Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin. Skelet. Muscle 2014, 4:2.
41. Selsby J.T., et al. Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse. PLoS ONE 2012, 7:e30063.
42. Hollinger K., et al. Rescue of dystrophic skeletal muscle by PGC-1α involves restored expression of dystrophin-associated protein complex components and satellite cell signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 305:R13-R23.
43. Chakkalakal J.V., et al. Retrograde influence of muscle fibers on their innervation revealed by a novel marker for slow motoneurons. Development 2010, 137:3489-3499.
44. Da Cruz S., et al. Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab. 2012, 15:778-786.
45. Buchman A.S., et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 2012, 78:1323-1329.
46. Adamson B.C., et al. Effect of exercise on depressive symptoms in adults with neurological disorders: a systematic review and meta-analysis. Arch. Phys. Med. Rehabil. 2015, Published online January 13, 2015. 10.1016/j.apmr.2015.01.005.
47. Agudelo L.Z., et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 2014, 159:33-45.
48. Dantzer R., et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
49. Muller N., Schwarz M.J. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol. Psychiatry 2007, 12:988-1000.
50. Kuipers S.D., Bramham C.R. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr. Opin. Drug Discov. Dev. 2006, 9:580-586.
51. Wrann C.D., et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 2013, 18:649-659.
52. Bostrom P., et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
53. Handschin C., Spiegelman B.M. The role of exercise and PGC1α in inflammation and chronic disease. Nature 2008, 454:463-469.
54. Remels A.H., et al. TNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia?. FASEB J. 2010, 24:5052-5062.
55. Patti M.E., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8466-8471.
56. Remels A.H., et al. Regulation of skeletal muscle oxidative phenotype by classical NF-(B signalling. Biochim. Biophys. Acta 2013, 1832:1313-1325.
57. Feingold K.R., et al. Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm. J. Lipid Res. 2009, 50:2055-2063.
58. Puigserver P., et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγ coactivator-1. Mol. Cell 2001, 8:971-982.
59. Yu X.X., et al. Impact of endotoxin on UCP homolog mRNA abundance, thermoregulation, and mitochondrial proton leak kinetics. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E433-E446.
60. Olesen J., et al. Skeletal muscle PGC-1α is required for maintaining an acute LPS-induced TNFα response. PLoS ONE 2012, 7:e32222.
61. Gleyzer N., Scarpulla R.C. PGC-1-related coactivator (PRC), a sensor of metabolic stress, orchestrates a redox-sensitive program of inflammatory gene expression. J. Biol. Chem. 2011, 286:39715-39725.
62. Gleyzer N., Scarpulla R.C. Activation of a PGC-1-related coactivator (PRC)-dependent inflammatory stress program linked to apoptosis and premature senescence. J. Biol. Chem. 2013, 288:8004-8015.
63. Handschin C., et al. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J. Clin. Invest. 2007, 117:3463-3474.
64. Eisele P.S., et al. The peroxisome proliferator-activated receptor gamma coactivator 1α/β (PGC-1) coactivators repress the transcriptional activity of NF-κB in skeletal muscle cells. J. Biol. Chem. 2013, 288:2246-2260.
65. Bakkar N., et al. IKK/NF-κB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 2008, 180:787-802.
66. Bakkar N., et al. IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. J. Cell Biol. 2012, 196:497-511.
67. Hofmann T., et al. Irisin as a muscle-derived hormone stimulating thermogenesis - a critical update. Peptides 2014, 54:89-100.
68. Albrecht E., et al. Irisin - a myth rather than an exercise-inducible myokine. Sci. Rep. 2015, 5:8889.
69. Lee P., et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014, 19:302-309.
70. Roberts L.D., et al. β-Aminoisobutyric acid induces browning of white fat and hepatic beta-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 2014, 19:96-108.
71. Rao R.R., et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014, 157:1279-1291.
72. Zhang C., et al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 2012, 55:183-193.
73. Shan T., et al. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J. 2013, 27:1981-1989.
74. Arany Z., et al. Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1α and oxidative phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4721-4726.
75. 3-adrenergic receptor activation to transcriptional and physiological components of adaptive thermogenesis. J. Biol. Chem. 2012, 287:9100-9111.
76. Wen X., et al. Effect of exercise intensity on isoform-specific expressions of NT-PGC-1 alpha mRNA in mouse skeletal muscle. Biomed Res. Int. 2014, 2014:402175.
77. Wu Z., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
78. St-Pierre J., et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells. J. Biol. Chem. 2003, 278:26597-26603.
79. Rowe G.C., et al. Disconnecting mitochondrial content from respiratory chain capacity in PGC-1-deficient skeletal muscle. Cell Rep. 2013, 3:1449-1456.
80. He X., et al. Peri-implantation lethality in mice lacking the PGC-1-related coactivator protein. Dev. Dyn. 2012, 241:975-983.
81. Vercauteren K., et al. Short hairpin RNA-mediated silencing of PRC (PGC-1-related coactivator) results in a severe respiratory chain deficiency associated with the proliferation of aberrant mitochondria. J. Biol. Chem. 2009, 284:2307-2319.
82. Handschin C., et al. An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7111-7116.
83. Wu H., et al. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 2002, 296:349-352.
84. Akimoto T., et al. Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway. J. Biol. Chem. 2005, 280:19587-19593.
85. Jager S., et al. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12017-12022.
86. Barres R., et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012, 15:405-411.
87. Barres R., et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 2013, 3:1020-1027.
88. Nader G.A., et al. Resistance exercise training modulates acute gene expression during human skeletal muscle hypertrophy. J. Appl. Physiol. (1985) 2014, 116:693-702.
89. Ydfors M., et al. The truncated splice variants, NT-PGC-1α and PGC-1α4, increase with both endurance and resistance exercise in human skeletal muscle. Physiol. Rep. 2013, 1:e00140.
90. Lundberg T.R., et al. Truncated splice variant PGC-1α4 is not associated with exercise-induced human muscle hypertrophy. Acta Physiol. (Oxf.) 2014, 212:142-151.
91. Koves T.R., et al. Peroxisome proliferator-activated receptor-γ co-activator 1α-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. 2005, 280:33588-33598.
92. Mortensen O.H., et al. PGC-1β is downregulated by training in human skeletal muscle: no effect of training twice every second day vs. once daily on expression of the PGC-1 family. J. Appl. Physiol. (1985) 2007, 103:1536-1542.
93. Wang L., et al. Resistance exercise enhances the molecular signaling of mitochondrial biogenesis induced by endurance exercise in human skeletal muscle. J. Appl. Physiol. (1985) 2011, 111:1335-1344.
94. Knutti D., et al. Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9713-9718.
95. Fan M., et al. Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1α: modulation by p38 MAPK. Genes Dev. 2004, 18:278-289.
96. + metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
97. Lerin C., et al. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1α. Cell Metab. 2006, 3:429-438.
98. Teyssier C., et al. Activation of nuclear receptor coactivator PGC-1α by arginine methylation. Genes Dev. 2005, 19:1466-1473.
99. Housley M.P., et al. A PGC-1α-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J. Biol. Chem. 2009, 284:5148-5157.
100. Trausch-Azar J.S., et al. Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α. J. Cell. Physiol. 2015, 230:842-852.
101. Olson B.L., et al. SCFCdc4 acts antagonistically to the PGC-1α transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes Dev. 2008, 22:252-264.
102. Ruan H.B., et al. O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability. Cell Metab. 2012, 16:226-237.
103. Wei P., et al. RNF34 is a cold-regulated E3 ubiquitin ligase for PGC-1α and modulates brown fat cell metabolism. Mol. Cell. Biol. 2012, 32:266-275.